Mirtazapine Tablet, Film Coated
Product Images NDC 13107-032

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Mirtazapine (NDC 13107-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurolife Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel-7.5 mg 500 Tablets Bottle (Mirtazapine Fig1)

Mirtazapine Tablets, USP is a prescription medicine that comes in a container of 500 tablets, each containing 7.5 mg mirtazapine USP. It is distributed by Aurobindo Pharma USA Inc. The usual dosage and prescribing information are provided separately. The medicine should be dispensed in a tight, light-resistant container as described in the USP. The recommended storage temperature is between 15° and 30°C (58° to 86°F). This information was revised in April 2017.*

FDA Label Image

Mirtazapine Fig2

This is the label of a medication bottle containing 15 mg mirtazapine tablets manufactured by Aurobindo Pharma USA, Inc. The recommended dosage and instructions for use are provided inside the enclosed prescribing information. The tablets are to be stored at room temperature and dispensed by a pharmacist with a medication guide provided separately. There is a batch number and an expiration date listed towards the end of the label.*

FDA Label Image

Mirtazapine Fig3

Mirtazapine Tablets, USP is a medication that can only be dispensed by a pharmacist, containing 3 mg of mirazaping. It is manufactured by Aurobindo Pharma USA and comes in a container described in the USP. The recommended dosage should be determined by a healthcare provider. The medication guide should be provided separately and it should be stored at a temperature range permitted from 15 °C to 30 °C. The tablets were packaged on April 2017.*

FDA Label Image

Package Label-principal Display Panel-15 mg 500 Tablets Bottle (Mirtazapine Fig4)

This is a pharmaceutical package of Trazapine Tablets, USP manufactured by Aurobindo. The medication guide is provided separately and the dosage information should be obtained from a pharmacist. The package contains 45 mg of Mirazapine tablets and should be stored in a temperature-controlled room per USP guidelines. The batch was manufactured in April 2017 and the package is intended for dispensing to patients based on prescription information.*

FDA Label Image

Mirtazpine Structure (Mirtazapine Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.